No images? Click here

Thursday, 18 August 2022

POST PRESSER LINKS

Virtual Press Conference on an extraordinary meeting for the Strategic Advisory Group of Experts on Immunization (SAGE)

Please find below links from the VPC held earlier today on the outcomes of an extraordinary meeting for the Strategic Advisory Group of Experts on Immunization (SAGE) to propose recommendations to WHO on the use of COVID-19 vaccines.

Audio file:

https://who.canto.global/b/LM2R8

Video file:

Available on request

LINKS TO SAGE STATEMENT, RECOMMENDATIONS, AND OTHER DOCUMENTS

Good Practice Statement on the use of a second booster doses for COVID-19 vaccines, 18 August 2022 (WHO/2019-nCoV/Vaccines/SAGE/Boosters/2022.1):

http://apps.who.int/iris/bitstream/handle/10665/361714/WHO-2019-nCoV-Vaccines-SAGE-Boosters-2022.1-eng.pdf

Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19, updated 18 August 2022 (WHO/2019-nCoV/vaccines/SAGE_recommendation/mRNA-1273/2022.2):

https://apps.who.int/iris/bitstream/handle/10665/361718/WHO-2019-nCoV-vaccines-SAGE-recommendation-mRNA-1273-2022.2-eng.pdf

Annexes to the recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19 (WHO/2019-nCoV/vaccines/SAGE_recommendation/mRNA-1273/annexes/2022.2):

https://apps.who.int/iris/bitstream/handle/10665/341788/WHO-2019-nCoV-vaccines-SAGE-recommendationm-RNA-1273-annexes-2021.2-eng.pdf

Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under emergency use listing (WHO/2019-nCoV/vaccines/SAGE_recommendation/BNT162b2/2022.2):

https://apps.who.int/iris/bitstream/handle/10665/361720/WHO-2019-nCoV-vaccines-SAGE-recommendation-BNT162b2-2022.2-eng.pdf

Annexes to the recommendations for use of the Pfizer–BioNTech vaccine BNT162b2 against COVID-19 (WHO/2019-nCoV/vaccines/SAGE_recommendation/BNT162b2/annexes/2022.2):

https://apps.who.int/iris/bitstream/handle/10665/361721/WHO-2019-nCoV-vaccines-SAGE-recommendation-BNT162b2-annexes-2022.2-eng.pdf

Interim recommendations for use of the Valneva vaccine, VLA2001 against COVID-19, 18 August 2022 (WHO/2019-nCoV/vaccines/SAGE_recommendation/VLA2001/2022.1):

https://apps.who.int/iris/bitstream/handle/10665/361716/WHO-2019-nCoV-vaccines-SAGE-recommendation-VLA2001-2022.1-eng.pdf

Annexes to the recommendations for use of the Valneva VLA2001 vaccine against COVID 19 (WHO/2019-nCoV/vaccines/SAGE_recommendation//VLA2001/annexes/2022.1):

https://apps.who.int/iris/bitstream/handle/10665/361715/WHO-2019-nCoV-vaccines-SAGE-recommendation-VLA2001-annexes-2022.1-eng.pdf

Background to the recommendations for use of the Valneva VLA2001 vaccine against COVID 19 (WHO/2019-nCoV/vaccines/SAGE_recommendation//VLA2001/background/2022.1):
https://apps.who.int/iris/bitstream/handle/10665/361717/WHO-2019-nCoV-vaccines-SAGE-recommendation-VLA2001-background-2022.1-eng.pdf

11 August Meeting link:

Extraordinary meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) – 11 August 2022

More about the Strategic Advisory Group of Experts on Immunization

Media contacts:

mediainquries@who.int

You are receiving this NO-REPLY email because you are included on a WHO mail list.
If you have been forwarded this update you can click here to subscribe.
Journalists may send feedback to WHO Media Team